Roxana Mehran talks with Robert Harrington, the new Dean of Weill Cornell Medicine, about his move to New York and plans for ...

Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.

Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

Nontraditional risk factors, particularly migraine with aura, play a major role in patients under 50 years old.

Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

This month: shorter recovery after TAVI, Down syndrome CV insights, the benefits of brisker walking, and more.

Juan Granada, MD, and Brian Lindman, MD, share insights on tools and data that can be used to ahieve earlier diagnosis and ...

Numerous components beyond length of sleep have important ties to cardiometabolic disease and related risk factors.

For all the different subpopulations, having a CAC score > 100 strongly predicted risk of CV death (P < 0.007). Yet the ...

Added information from the assays could guide care, especially for intermediate-risk patients on the cusp of initiating ...

Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...